Abstract
This review provides a comprehensive overview of autism spectrum disorder (ASD), focusing on its early signs, clinical presentation, etiology, screening and diagnosis, therapeutic interventions, and the critical role of family support. ASD characterized by a range of challenges in social communication, behavior, and sensory processing, with symptoms manifesting in early childhood. While the exact causes remain unclear, a combination of genetic and environmental factors believed to contribute to its development. Early screening and diagnosis are essential for effective intervention, utilizing standardized tools and structured assessments to identify individuals at risk. Therapeutic approaches, such as Applied Behavior Analysis (ABA), speech therapy, and occupational therapy, are vital for enhancing communication skills and overall functioning. Additionally, family support plays a crucial role in promoting acceptance and understanding, fostering a nurturing environment that aids in the individual's development. Gene-environment interactions, including maternal stress and environmental toxins, influence neurodevelopmental disorders like ASD, with Sirtuin 1 (SIRT1) playing a key role in disease pathophysiology. Modulating SIRT1 through activators or inhibitors, along with targeting metabolic pathways, may offer new therapeutic strategies for ASD. This review also underscores the importance of awareness and advocacy in creating inclusive communities that support individuals with autism and their families, ultimately enhancing their quality of life and enabling them to reach their full potential.
Keywords
Autism spectrum disorder, Awareness, Diagnosis, Therapeutic approaches
Introduction to Autism Spectrum Disorder
Autism Spectrum Disorder (ASD) is a multifaceted neurodevelopmental disorder marked by impairments in social interaction and communication alongside restricted and repetitive behaviors. ASD manifests early in childhood and persists throughout a person’s life, though the severity and range of symptoms vary widely, hence the term “spectrum” [1]. With rising diagnosis rates, ASD now affects approximately 1 in 36 children in the United States, according to the CDC’s 2022 data, a trend partially attributed to advancements in diagnostic practices and heightened awareness among clinicians and the public [2]. Autism was first described in the 1940s when child psychiatrist Leo Kanner identified a group of children displaying “autistic aloneness” and “insistence on sameness” [3]. Around the same time, Austrian pediatrician Hans Asperger observed similar traits in children with higher verbal abilities, later leading to the identification of Asperger’s Syndrome as a distinct condition within the autism spectrum. These early observations laid the groundwork for understanding ASD as a heterogeneous condition.
The understanding of ASD’s diagnostic criteria has evolved significantly over time. Initially, autism and Asperger’s syndrome were classified as separate entities within the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), which recognized autism as part of the broader category of pervasive developmental disorders (PDD) (American Psychiatric Association, 1994). However, in 2013, the DSM-5 unified these conditions under the single category of ASD, with a focus on two primary symptom domains: (1) social communication and interaction deficits and (2) restricted, repetitive patterns of behavior (American Psychiatric Association, 2013). This change streamlined the diagnostic process but also prompted debates, particularly concerning individuals who identified with the former Asperger's diagnosis [4].
The prevalence of ASD has increased dramatically over the last few decades. While this increase has led to greater public and scientific attention, it has also raised questions about whether ASD is indeed more common today or if improvements in awareness, screening, and diagnosis account for much of the observed rise. The CDC’s Autism and Developmental Disabilities Monitoring (ADDM) Network reports prevalence rates in the U.S. rose from 1 in 150 children in 2000 to 1 in 36 by 2022, largely due to refined diagnostic methods and a broader understanding of the condition’s diverse presentations. Studies also suggest that factors like older parental age and certain perinatal risks might contribute to the rise, though these associations remain under investigation [5].
While ASD prevalence varies globally, cultural, socioeconomic, and regional factors contribute to differences in diagnosis rates. A meta-analysis revealed that while North America and Europe report high ASD prevalence, under diagnosis remains a concern in low- and middle-income countries (LMICs). In these regions, social stigma, limited mental health resources, and restricted access to diagnostic services may prevent many individuals with ASD from receiving timely diagnosis and intervention. Cultural perceptions of developmental milestones also influence recognition, as some societies may perceive certain behaviors differently than clinical standards, impacting the likelihood of an ASD diagnosis [6,7].
Efforts to harmonize diagnostic criteria globally and reduce disparities in ASD diagnosis are underway. International programs such as the WHO's MH GAP initiative aim to improve mental health access worldwide, specifically targeting ASD and developmental disorders in LMICs by providing training and resources for healthcare workers (World Health Organization, 2015). Despite these initiatives, significant barriers remain, underscoring the need for further global collaboration to ensure accessible and culturally sensitive diagnostic and treatment pathways for ASD. ASD is currently understood as a neurodevelopmental condition with both genetic and environmental components, influencing the brain's development and structure. Early research has identified certain biomarkers and neuroimaging profiles that may one day aid in the early identification of ASD in at-risk infants, though no biomarkers are yet diagnostic [8]. The heterogeneity within ASD also presents a challenge, as individuals with ASD can vary greatly in terms of cognitive function, language skills, and behavior.
Ongoing research seeks to refine ASD diagnosis further, incorporating genetic, epigenetic, and neuroimaging data to create more individualized diagnostic tools and treatments. Early intervention is already known to improve developmental outcomes, and further advancements in diagnostic and screening methods may enable even earlier identification, paving the way for more tailored and effective interventions [9].
Etiology of ASD
Understanding the etiology of ASD is complex due to the interaction of multiple factors. Research indicates that both genetic and environmental influences contribute to the risk of developing ASD, often through intricate gene-environment interactions. Research shows that genetics play a significant role in the development of ASD, with heritability estimates ranging from 50% to 90%, indicating a strong genetic contribution [10]. Large-scale genomic studies have identified numerous genes associated with ASD. Key findings include De Novo Mutations: These mutations arise spontaneously in an individual's genome and are often not present in the parents. Studies have shown that de novo mutations in genes like CHD8 and SHANK3 are significantly associated with ASD [11]. These genes are crucial for synaptic function and neuronal development.
Copy Number Variations (CNVs): CNVs are segments of DNA that are duplicated or deleted in the genome. Certain CNVs, such as those involving the 16p11.2 region, have been linked to an increased risk of ASD [12]. These CNVs can disrupt gene function and contribute to neurodevelopmental disorders. Polygenic Risk Scores (PRS): The concept of PRS involves aggregating the effects of multiple genetic variants to assess an individual's risk for ASD. Individuals with higher PRS for ASD exhibit greater phenotypic expression of autism traits, suggesting that cumulative genetic risk may play a crucial role in the disorder's onset [13].
Twin studies have been instrumental in elucidating the heritability of ASD. Research shows that identical twins have a higher concordance rate for ASD than fraternal twins, with estimates around 77% for identical twins compared to 31% for fraternal twins [14]. This significant difference reinforces the genetic component of ASD and highlights the interplay of genetic and environmental factors in its etiology. While genetic factors are critical, environmental influences also significantly contribute to the risk of developing ASD.
Advanced maternal age has been associated with an increased risk of having a child with ASD. Studies indicate that mothers over 35 years old at the time of delivery may have a higher risk compared to younger mothers [15].
Maternal infections during pregnancy, such as rubella, cytomegalovirus, and influenza, have been linked to an increased risk of ASD. A study by Atladóttir et al. suggested that maternal viral infections during the first trimester could influence fetal brain development, leading to a higher risk of ASD [16].
Exposure to environmental toxins, such as pesticides and heavy metals, has been studied for its association with ASD. For instance, a study highlighted a correlation between maternal exposure to organophosphate pesticides and increased risk of ASD in offspring [17]. Maternal immune activation (MIA) during pregnancy has gained attention as a potential risk factor for ASD. MIA can occur due to infections or inflammatory responses, potentially influencing neurodevelopment in the fetus. The elevated levels of pro-inflammatory cytokines during pregnancy can disrupt normal brain development, possibly increasing the risk of ASD in the child [18]. Gene-environment interactions occur when environmental factors influence the expression of genetic predispositions. For instance, a child with a genetic vulnerability to ASD may be more susceptible to the effects of environmental toxins, leading to a higher risk of developing the disorder [19]. Epigenetic mechanisms involve changes in gene expression without altering the underlying DNA sequence. Environmental factors such as nutrition, stress, and toxins can induce epigenetic changes that influence neurodevelopment. Research indicates that maternal exposure to certain environmental stressors can lead to epigenetic modifications in the developing fetus, potentially impacting brain development and increasing ASD risk [20]. For example, a study suggested that early life stress could result in long-term epigenetic changes affecting gene expression related to neurodevelopment [21].
Gene-environment interactions play a crucial role in neurodevelopmental disorders such as ASD, where environmental factors like nutrition, stress, and toxins influence genetic predispositions through epigenetic modifications. Maternal exposure to environmental stressors can lead to alterations in gene expression that impact fetal brain development, thereby increasing ASD risk. Sirtuin 1 (SIRT1), an anti-aging gene, is particularly significant in metabolic and neurodegenerative diseases, with growing evidence suggesting its potential role in ASD pathophysiology. Research indicates that SIRT1 activators and inhibitors may hold therapeutic promise for ASD, necessitating further exploration of plasma SIRT1 levels as a potential biomarker for disease monitoring and intervention [20]. Moreover, dysregulated metabolic pathways, including those related to caffeine metabolism and non-alcoholic fatty liver disease (NAFLD), have been implicated in neurological dysfunction and may intersect with SIRT1 pathways [21]. As SIRT1 is associated with cellular senescence, apoptosis, and appetite regulation, its modulation could offer novel therapeutic avenues for ASD management, reinforcing the need for targeted nutritional and pharmacological strategies [22].
Epigenetic mechanisms involve changes in gene expression without altering the underlying DNA sequence. Environmental factors such as nutrition, stress, and toxins can induce epigenetic changes that influence neurodevelopment. Research indicates that maternal exposure to certain environmental stressors can lead to epigenetic modifications in the developing fetus, potentially impacting brain development and increasing ASD risk [23]. For example, a study suggested that early life stress could result in long-term epigenetic changes affecting gene expression related to neurodevelopment [24].
Clinical Manifestations of ASD
ASD is characterized by a heterogeneous presentation of symptoms that can vary widely among individuals. Understanding the clinical manifestations of ASD is crucial for early diagnosis, intervention, and management. This section explores the core symptoms, associated features, co-occurring conditions, and the variability of presentations in individuals with ASD.
The core symptoms of ASD are typically classified into two primary domains: social communication deficits and restricted, repetitive patterns of behavior.
Social reciprocity: Individuals with ASD often struggle with the back-and-forth nature of social interactions. They may have difficulty initiating or responding to social overtures, leading to challenges in forming relationships [25]. For instance, a child may not engage in pretend play or show interest in the activities of peers.
Nonverbal communication: Many individuals with ASD exhibit atypical use of nonverbal communication, such as eye contact, facial expressions, and gestures. Children with ASD may have difficulty interpreting social cues, which can hinder their ability to communicate effectively [26].
Language development: Language impairments are common in ASD, with some individuals remaining nonverbal while others exhibit delayed or atypical language development. Echolalia (repetition of phrases or sentences) is a common feature in some individuals, often serving as a means of communication [27].
Repetitive movements: Individuals with ASD may engage in repetitive motor movements, such as hand flapping, rocking, or spinning. These behaviors can serve as a means of self-regulation or sensory stimulation
(American Psychiatric Association, 2013).
Insistence on Sameness: A strong preference for routines and resistance to change is characteristic of many individuals with ASD. This may manifest as distress during transitions or when faced with unexpected changes [28].
Fixated interests: Some individuals with ASD may develop intense and focused interests in specific topics or objects. These interests can be a source of joy and motivation, but they may also limit engagement in other activities [29].
Many individuals with ASD experience atypical sensory processing, which can manifest as hypersensitivity or hyposensitivity to sensory stimuli. For example, some individuals may be overwhelmed by loud noises or bright lights, while others may seek out intense sensory experiences [30]. These sensory differences can significantly impact daily life and social interactions.
Cognitive profiles in individuals with ASD can vary widely. While some individuals may have intellectual disabilities, others may demonstrate average or above-average intelligence. A subset of individuals with ASD, often referred to as "savants," may exhibit exceptional abilities in specific areas, such as mathematics, music, or art.
Many individuals with ASD present with co-occurring conditions that can complicate diagnosis and treatment. Understanding these comorbidities is essential for comprehensive care.
Attention-deficit/hyperactivity disorder (ADHD): Research suggests a significant overlap between ASD and ADHD, with many individuals exhibiting symptoms of both disorders. A study found that 30-80% of individuals with ASD also meet criteria for ADHD, impacting their attention and impulse control [31].
Anxiety disorders: Anxiety is common among individuals with ASD, with prevalence rates estimated at 40-50% [32]. Anxiety can exacerbate social difficulties and lead to increased behavioral challenges.
Depression: Adolescents and adults with ASD may be at heightened risk for depression, particularly as they navigate social challenges and the transition to adulthood [33]. Early identification and intervention for depression are crucial for improving outcomes.
Intellectual disabilities: Intellectual disabilities are common in individuals with ASD, with estimates suggesting that 30-50% of individuals with autism have an intellectual disability [34]. The severity of cognitive impairment can significantly impact functional outcomes and intervention needs.
The "spectrum" nature of ASD reflects the wide range of abilities and challenges that individuals may experience. DSM-5 recognizes this variability by categorizing ASD into different levels of support needs (American Psychiatric Association, 2013).
Level 1 (requiring support): Individuals at this level may struggle with social interactions and exhibit inflexibility in behavior but can generally function with support.
Level 2 (requiring substantial support): Individuals at this level have more pronounced difficulties in social communication and require significant support to manage daily activities.
Level 3 (Requiring Very Substantial Support): Individuals at this level exhibit severe challenges in communication and behavior, requiring intensive support for daily functioning.
Research indicates that ASD may present differently in males and females, with females often exhibiting less overt symptoms and potentially being underdiagnosed. A study found that females with ASD might exhibit stronger social motivation and better camouflage skills, which can complicate the diagnostic process [35].
Screening and Diagnosis
The American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders (DSM) is essential for the diagnosis and classification of ASD. The DSM provides specific diagnostic criteria, ensuring consistency and accuracy in assessments; as outlined in the DSM-5, ASD is characterized by persistent deficits in social communication and interaction, alongside restricted and repetitive behaviors. Recognizing autism as a spectrum, the DSM-5 reflects the diverse range of symptoms and levels of impairment, consolidating previously distinct categories under one umbrella to emphasize the continuity of symptoms. Early diagnosis is underscored as crucial for timely interventions that can significantly improve outcomes.
Additionally, DSM acknowledges common comorbid conditions, such as anxiety and ADHD, which often accompany autism, and encourages culturally sensitive assessments to prevent misdiagnosis. The criteria set forth in the DSM not only guide research and treatment approaches but also influence public policy and access to services for individuals with autism. As the DSM is periodically updated to incorporate new research findings, it remains a vital resource for clinicians, researchers, and policymakers in understanding and addressing the complexities of ASD [36].
In 2022, the DSM-5-TR (Text Revision) version includes updates and clarifications to the existing criteria, reflecting new research findings, clinical insights, and a better understanding of disorders. It also addresses the language used to describe disorders, aiming for more sensitivity and inclusivity.
The DSM-5-TR outlines specific criteria for diagnosing ASD, organized into two main domains. First, individuals must exhibit persistent deficits in social communication and interaction across three areas: social-emotional reciprocity, which includes challenges in back-and-forth conversation and responding to social cues; nonverbal communicative behaviors, such as difficulties with gestures and eye contact; and the ability to develop and maintain relationships, including issues with forming peer connections and engaging in imaginative play. Second, individuals must demonstrate at least two restricted and repetitive patterns of behavior, interests, or activities. This can manifest as stereotyped motor movements (like hand-flapping), insistence on sameness (showing distress at minor changes), highly restricted interests (intense focus on specific topics), or unusual sensory responses (such as hypersensitivity to sounds). Symptoms typically arise in early childhood, although they may not fully manifest until social demands exceed the individual's capabilities.
To qualify for a diagnosis, these symptoms must cause clinically significant impairment in social, occupational, or other important areas of functioning and cannot be better explained by another condition. This comprehensive framework ensures accurate diagnosis and appropriate support for individuals with ASD [37].
There are several standardized tests and assessments used to evaluate ASD and assist in diagnosing the condition. Among the most prominent tools is the Autism Diagnostic Observation Schedule (ADOS), a semi-structured assessment involving direct observation of the individual’s behavior in various social and communication contexts. The Autism Diagnostic Interview-Revised (ADI-R) is another critical tool; this structured interview with parents or caregivers focuses on the child's developmental history and current behaviors, assessing core areas such as social interaction and communication. The Childhood Autism Rating Scale (CARS) is a behavioral rating scale that identifies children with autism and estimates the severity of the disorder by evaluating 15 different behavioral domains through observational data.
For younger children, the Modified Checklist for Autism in Toddlers (M-CHAT) serves as a parent-completed screening tool designed for toddlers aged 16 to 30 months, helping to identify those at risk for autism. The Inventory for Social and Affective Assessment (ISAA) focuses on measuring social and emotional functioning, evaluating aspects such as social engagement and emotional regulation. Additionally, the Social Responsiveness Scale (SRS) is completed by parents or teachers to assess social behavior and the severity of social impairment. Cognitive assessments, such as the Wechsler Intelligence Scale for Children (WISC), provide insights into intellectual functioning, while the Vineland Adaptive Behavior Scales measure adaptive behaviors, including daily living skills and communication.
Other tools include the Parenting Stress Index (PSI), which assesses parental stress levels, and the Sensory Profile, evaluating sensory processing patterns in children. The Behavior Assessment System for Children (BASC) offers a comprehensive view of behavioral and emotional problems through a set of rating scales. These assessments, administered by trained professionals, contribute to an accurate diagnosis of autism and help inform appropriate interventions and support strategies tailored to the individual's unique needs [38].
Genetic Diagnostic Criteria for Autism
While ASD is primarily diagnosed based on behavioral criteria outlined in the DSM-5, genetic testing and evaluation can provide additional insights, especially in cases where there may be suspicion of genetic syndromes associated with autism. Chromosomal Microarray Analysis (CMA) is often the first-line genetic test for individuals with ASD. It can identify chromosomal abnormalities, such as deletions or duplications of genetic material that may be associated with autism or other developmental disorders [39].
In addition to CMA, genetic testing for specific syndromes associated with autism is also important. Conditions such as Fragile X syndrome, Rett syndrome, and 22q11.2 deletion syndrome may present with features that overlap with ASD. Genetic testing for these syndromes may be indicated, particularly if there are clinical signs or family histories that suggest these conditions.
Family history plays a significant role in genetic evaluations. If there is a known family history of ASD or related developmental disorders, it can provide important context regarding the likelihood of genetic factors contributing to the individual’s condition. Clinicians often assess family medical history to identify patterns that may suggest a hereditary component to the diagnosis of autism. Furthermore, when evaluating a patient, clinicians may look for phenotypic features or other health issues commonly associated with specific genetic syndromes. These may include intellectual disabilities, seizures, or distinctive physical characteristics, which can inform the overall assessment and guide potential interventions.
Ethical considerations are also paramount in the context of genetic testing. Families should be counseled about the implications of the results, including how they may impact treatment options, future family planning, and understanding the nature of the condition. Genetic testing can sometimes yield incidental findings—results unrelated to the initial reason for testing—which can have significant implications for the individual and their family. Therefore, discussions surrounding testing should include potential outcomes, both expected and unexpected.
Genetic counseling serves as an essential component of this process, offering support and education to families considering genetic testing. Counselors help interpret the results, providing context and guidance on the significance of any findings in relation to autism and the individual's overall health. They can also assist families in understanding the broader implications for family members and future generations.
It is important to note that while genetic testing can aid in identifying underlying causes in specific cases, there is currently no single genetic test for autism itself. The diagnosis of ASD remains primarily based on behavioral criteria, emphasizing the importance of comprehensive evaluation. Genetic testing serves as a complementary tool, enhancing the understanding of autism and allowing for tailored interventions based on the individual’s Unique profile. This integrated approach ensures that individuals with autism receive holistic care that addresses both their behavioral and potential genetic needs.
Therapies and Support for Autistic Child
There are various therapies available to support individuals with ASD, each targeting different aspects of development, behavior, and communication. Applied Behavior Analysis (ABA) is a widely used evidence-based approach that focuses on improving specific behaviors and reducing challenging behaviors through reinforcement strategies. Speech and language therapy enhances communication skills, including speech and nonverbal communication. Occupational therapy (OT) works on daily living skills, fine motor skills, and sensory integration to help individuals function effectively in everyday activities. Social skills training teaches interaction and understanding of social cues, while Cognitive Behavioral Therapy (CBT) addresses emotional challenges like anxiety and depression by promoting coping strategies. The Developmental, Individual Differences, Relationship-Based (DIR) model, or Floor time, focuses on emotional and developmental milestones through engaging play. Natural Language Acquisition (NLA) emphasizes communication in natural settings, and sensory integration therapy helps individuals manage sensory processing issues. Expressive therapies such as art and music therapy provide creative outlets for emotional communication [40], and animal-assisted therapy promotes social engagement through interactions with trained animals [39]. Mindfulness and relaxation techniques also help individuals manage anxiety and improve emotional regulation. A combination of these therapies can be tailored to meet the unique needs of each individual, effectively supporting their development and enhancing their quality of life [41].
Educational support, including Individualized Education Programs (IEPs) and special education services provide tailored plans and trained professionals to meet the specific needs of children with autism.
Additionally, family support programs offer training and resources to help parents navigate the challenges of raising a child with autism, while respite care provides temporary relief for families, reducing caregiver stress. Social and recreational programs designed specifically for children with autism promote social interaction and skill development in a supportive environment [42].
Advocacy services help families navigate educational and healthcare systems to ensure appropriate support, while transition services focus on preparing children for adulthood with vocational training and life skills programs.
These supports can be tailored to the unique needs of each child, fostering their development and enhancing their overall quality of life through collaboration among families, educators, and healthcare providers.
Conclusion
To conclude, ASD represents a diverse range of neurodevelopmental conditions that significantly impact individuals and their families. Understanding the nuances of ASD—its early signs, clinical presentation, causes, and the critical importance of screening and diagnosis—is essential for promoting timely and effective interventions. Therapeutic approaches play a vital role in enhancing the quality of life for those with autism, while family support is crucial for fostering an inclusive environment that encourages growth and acceptance. By embracing the concept of neurodiversity and advocating for increased awareness, we can create communities that not only recognize the unique strengths and challenges of individuals with autism but also support their full participation in society. Ultimately, a collaborative effort among families, healthcare professionals, educators, and the community is necessary to ensure that individuals with ASD are given the resources and opportunities they need to thrive. Through commitment to understanding and acceptance, we can build a more equitable world that values and uplifts the diverse experiences of all individuals on the autism spectrum.
References
2. Maenner MJ, Shaw KA, Bakian AV, Bilder DA, Durkin MS, Esler A, et al. Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2018. MMWR Surveill Summ. 2021 Dec 3;70(11):1-16.
3. Harris J. Leo Kanner and autism: a 75-year perspective. Int Rev Psychiatry. 2018 Feb;30(1):3-17.
4. Lord C, Petkova E, Hus V, Gan W, Lu F, Martin DM, et al. A multisite study of the clinical diagnosis of different autism spectrum disorders. Arch Gen Psychiatry. 2012 Mar;69(3):306-13.
5. Lyall K, Croen L, Daniels J, Fallin MD, Ladd-Acosta C, Lee BK, et al. The Changing Epidemiology of Autism Spectrum Disorders. Annu Rev Public Health. 2017 Mar 20;38:81-102.
6. Baxter AJ, Brugha TS, Erskine HE, Scheurer RW, Vos T, Scott JG. The epidemiology and global burden of autism spectrum disorders. Psychol Med. 2015 Feb;45(3):601-13.
7. Elsabbagh M, Divan G, Koh YJ, Kim YS, Kauchali S, Marcín C, et al. Global prevalence of autism and other pervasive developmental disorders. Autism Res. 2012 Jun;5(3):160-79.
8. Han J, Jiang G, Ouyang G, Li X. A Multimodal Approach for Identifying Autism Spectrum Disorders in Children. IEEE Trans Neural Syst Rehabil Eng. 2022;30:2003-11.
9. Zwaigenbaum L, Bauman ML, Stone WL, Yirmiya N, Estes A, Hansen RL, et al. Early Identification of Autism Spectrum Disorder: Recommendations for Practice and Research. Pediatrics. 2015 Oct;136(Suppl 1):S10-40.
10. Tick B, Bolton P, Happé F, Rutter M, Rijsdijk F. Heritability of autism spectrum disorders: a meta-analysis of twin studies. J Child Psychol Psychiatry. 2016 May;57(5):585-95.
11. De Rubeis S, He X, Goldberg AP, Poultney CS, Samocha K, Cicek AE, et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature. 2014 Nov 13;515(7526):209-15.
12. Kumar RA, Marshall CR, Badner JA, Babatz TD, Mukamel Z, Aldinger KA, et al. Association and mutation analyses of 16p11. 2 autism candidate genes. PloS One. 2009 Feb 26;4(2):e4582.
13. Weiner DJ, Wigdor EM, Ripke S, Walters RK, Kosmicki JA, Grove J, et al. Polygenic transmission disequilibrium confirms that common and rare variation act additively to create risk for autism spectrum disorders. Nature Genetics. 2017 Jul 1;49(7):978-85.
14. Tick B, Bolton P, Happé F, Rutter M, Rijsdijk F. Heritability of autism spectrum disorders: a meta‐analysis of twin studies. Journal of Child Psychology and Psychiatry. 2016 May;57(5):585-95.
15. O'Sullivan PB, Caneiro JP, O'Keeffe M, Smith A, Dankaerts W, Fersum K, et al. Cognitive Functional Therapy: An Integrated Behavioral Approach for the Targeted Management of Disabling Low Back Pain. Phys Ther. 2018 May 1;98(5):408-23. Erratum in: Phys Ther. 2018 Oct 1;98(10):903.
16. Atladóttir HO, Thorsen P, Østergaard L, Schendel DE, Lemcke S, Abdallah M, et al. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord. 2010 Dec; 40(12):1423-30.
17. Roberts EM, English PB, Grether JK, Windham GC, Somberg L, Wolff C. Maternal residence near agricultural pesticide applications and autism spectrum disorders among children in the California Central Valley. Environ Health Perspect. 2007 Oct; 115(10):1482-9.
18. Onore C, Careaga M, Ashwood P. The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun. 2012 Mar; 26(3):383-92.
19. Nardone S, Sams DS, Reuveni E, Getselter D, Oron O, Karpuj M, et al. DNA methylation analysis of the autistic brain reveals multiple dysregulated biological pathways. Transl Psychiatry. 2014 Sep 2; 4(9):e433.
20. Martins IJ. Anti-aging genes improve appetite regulation and reverse cell senescence and apoptosis in global populations. Advances in Aging Research. 2016;5:9-26.
21. Martins IJ. Nutrition therapy regulates caffeine metabolism with relevance to NAFLD and induction of type 3 diabetes. J Diabetes Metab Disord. 2017;4(1):1-9.
22. Martins I. Sirtuin 1, a diagnostic protein marker and its relevance to chronic disease and therapeutic drug interventions. EC Pharmacology and Toxicology. 2018;6(4):209-15.
23. Szyf M. Nongenetic inheritance and transgenerational epigenetics. Trends in Molecular Medicine. 2015 Feb 1;21(2):134-44.
24. Feil R, Fraga MF. Epigenetics and the environment: emerging patterns and implications. Nature Reviews Genetics. 2012 Feb; 13(2):97-109.
25. Lord C, Elsabbagh M, Baird G, Veenstra-Vanderweele J. Autism spectrum disorder. The lancet. 2018 Aug 11; 392(10146):508-20.
26. Charman T, Loth E, Tillmann J, Crawley D, Wooldridge C, Goyard D, et al. The EU-AIMS longitudinal European autism project (LEAP): Clinical characterisation. Molecular Autism. 2017 Dec; 8:27.
27. Tager-Flusberg H, Rogers S, Cooper J, Landa R, Lord C, Paul R, et al. Defining spoken language benchmarks and selecting measures of expressive language development for young children with autism spectrum disorders. J Speech Lang Hear Res. 2009 Jun;52(3):643-52.
28. Wong C, Odom SL, Hume KA, Cox AW, Fettig A, Kucharczyk S, et al. Evidence-Based Practices for Children, Youth, and Young Adults with Autism Spectrum Disorder: A Comprehensive Review. J Autism Dev Disord. 2015 Jul; 45(7):1951-66.
29. Klin A, Saulnier CA, Sparrow SS, Cicchetti DV, Volkmar FR, Lord C. Social and communication abilities and disabilities in higher functioning individuals with autism spectrum disorders: the Vineland and the ADOS. J Autism Dev Disord. 2007 Apr; 37(4):748-59.
30. Tomchek SD, Dunn W. Sensory processing in children with and without autism: a comparative study using the short sensory profile. Am J Occup Ther. 2007 Mar-Apr; 61(2):190-200.
31. Masi A, DeMayo MM, Glozier N, Guastella AJ. An Overview of Autism Spectrum Disorder, Heterogeneity and Treatment Options. Neurosci Bull. 2017 Apr;33(2):183-93.
32. Van Steensel FJ, Bögels SM, Perrin S. Anxiety disorders in children and adolescents with autistic spectrum disorders: A meta-analysis. Clinical Child and Family Psychology Review. 2011 Sep; 14:302-17.
33. Murray A, Koronczai B, Király O, Griffiths MD, Mannion A, Leader G, et al. Autism, problematic internet use and gaming disorder: A systematic review. Review Journal of Autism and Developmental Disorders. 2021 Mar 29;9:120-40.
34. Baio J. Prevalence of autism spectrum disorder among children aged 8 years—autism and developmental disabilities monitoring network, 11 sites, United States, 2014. MMWR. Surveillance summaries. 2018;67(6):1-23.
35. Lai MC, Lombardo MV, Pasco G, Ruigrok AN, Wheelwright SJ, Sadek SA, et al. A behavioral comparison of male and female adults with high functioning autism spectrum conditions. PloS One. 2011 Jun 13;6(6):e20835.
36. Thabtah F, Peebles D. Early autism screening: a comprehensive review. International Journal of Environmental Research and Public Health. 2019 Sep; 16(18):3502.
37. Yu Y, Ozonoff S, Miller M. Assessment of autism spectrum disorder. Assessment. 2024 Jan; 31(1):24-41.
38. Ehteshami S, Araghi NM, Pashmdarfard M. Psychometric properties of Autism Spectrum Disorders Screening Assessment Tools: Systematic Review. Medical Journal of the Islamic Republic of Iran. 2023 Nov 6; 37:117.
39. Beavers A, Fleming A, Shahidullah JD. Animal-assisted therapies for autism. Current Problems in Pediatric and Adolescent Health Care. 2023 Nov 1; 53(11):101478.
40. Toscano CV, Carvalho HM, Ferreira JP. Exercise effects for children with autism spectrum disorder: metabolic health, autistic traits, and quality of life. Perceptual and Motor Skills. 2018 Feb; 125(1):126-46.
41. Sharda M, Silani G, Specht K, Tillmann J, Nater U, Gold C. Music therapy for children with autism: investigating social behaviour through music. The Lancet Child & Adolescent Health. 2019 Nov 1; 3(11):759-61.
42. Chaidi I, Drigas A. Parents' involvement in the education of their children with Autism: Related research and its results. International Journal of Emerging Technologies In Learning (IJET). 2020 Jul 31; 15(14):194-203.